Attached files
| file | filename |
|---|---|
| EX-10.2 - EXHIBIT 10.2 - LUMOS PHARMA, INC. | nlnk-20170105x8kxex102.htm |
| 8-K - 8-K - LUMOS PHARMA, INC. | nlnk-20170105x8k.htm |
Exhibit 10.1
2016 Bonus Awards and Supplemental Bonus Awards | |||||
Name and Title | 2016 Annual Salary | Goal Bonus at 100% | Bonus Awarded | Bonus Amount | Supplemental Bonus Amount |
Charles J. Link, Jr., M.D. | $659,900 | $461,930 | 50% | $230,965 | $55,000 |
Chairman of the Board and Chief Executive and Scientific Officer | |||||
Nicholas N. Vahanian, M.D. | $574,300 | $287,150 | 50% | $143,575 | $43,000 |
Director, President and Chief Medical Officer | |||||
John B. Henneman, III | $423,600 | $169,440 | 50% | $84,720 | $26,250 |
Chief Financial Officer | |||||
Carl Langren | $277,500 | $83,250 | 50% | $41,625 | $12,625 |
Vice President of Finance | |||||
Brian Wiley | $370,700 | $129,745 | 50% | $64,873 | $19,525 |
Chief Commercial Officer | |||||